Abstract
Summary
The global market for Cystic Fibrosis Diagnostic Tests was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Cystic Fibrosis Diagnostic Tests, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Cystic Fibrosis Diagnostic Tests by region & country, by Type, and by Application.
The Cystic Fibrosis Diagnostic Tests market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cystic Fibrosis Diagnostic Tests.
Market Segmentation
By Company
Quidel Corporation
Quest Diagnostics
Creative Diagnostics
Invitae Corporation
Asper Biogene
GeneDx
Illumina
Elucigene Diagnostics
BillionToOne Inc.
ELITechGroup
Segment by Type:
Genetic Tests
Fecal Test
Immunoreactive Trypsinogen (IRT) Test
Sweat Chloride Tests
Pulmonary Function Tests
Segment by Application
Hospitals
Diagnostic Laboratories
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Cystic Fibrosis Diagnostic Tests manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Cystic Fibrosis Diagnostic Tests in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Cystic Fibrosis Diagnostic Tests in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Cystic Fibrosis Diagnostic Tests, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Cystic Fibrosis Diagnostic Tests by region & country, by Type, and by Application.
The Cystic Fibrosis Diagnostic Tests market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cystic Fibrosis Diagnostic Tests.
Market Segmentation
By Company
Quidel Corporation
Quest Diagnostics
Creative Diagnostics
Invitae Corporation
Asper Biogene
GeneDx
Illumina
Elucigene Diagnostics
BillionToOne Inc.
ELITechGroup
Segment by Type:
Genetic Tests
Fecal Test
Immunoreactive Trypsinogen (IRT) Test
Sweat Chloride Tests
Pulmonary Function Tests
Segment by Application
Hospitals
Diagnostic Laboratories
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Cystic Fibrosis Diagnostic Tests manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Cystic Fibrosis Diagnostic Tests in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Cystic Fibrosis Diagnostic Tests in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Table of Contents
1 Market Overview
1.1 Cystic Fibrosis Diagnostic Tests Product Introduction
1.2 Global Cystic Fibrosis Diagnostic Tests Market Size Forecast
1.3 Cystic Fibrosis Diagnostic Tests Market Trends & Drivers
1.3.1 Cystic Fibrosis Diagnostic Tests Industry Trends
1.3.2 Cystic Fibrosis Diagnostic Tests Market Drivers & Opportunity
1.3.3 Cystic Fibrosis Diagnostic Tests Market Challenges
1.3.4 Cystic Fibrosis Diagnostic Tests Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Cystic Fibrosis Diagnostic Tests Players Revenue Ranking (2023)
2.2 Global Cystic Fibrosis Diagnostic Tests Revenue by Company (2019-2024)
2.3 Key Companies Cystic Fibrosis Diagnostic Tests Manufacturing Base Distribution and Headquarters
2.4 Key Companies Cystic Fibrosis Diagnostic Tests Product Offered
2.5 Key Companies Time to Begin Mass Production of Cystic Fibrosis Diagnostic Tests
2.6 Cystic Fibrosis Diagnostic Tests Market Competitive Analysis
2.6.1 Cystic Fibrosis Diagnostic Tests Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Cystic Fibrosis Diagnostic Tests Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cystic Fibrosis Diagnostic Tests as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Genetic Tests
3.1.2 Fecal Test
3.1.3 Immunoreactive Trypsinogen (IRT) Test
3.1.4 Sweat Chloride Tests
3.1.5 Pulmonary Function Tests
3.2 Global Cystic Fibrosis Diagnostic Tests Sales Value by Type
3.2.1 Global Cystic Fibrosis Diagnostic Tests Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Cystic Fibrosis Diagnostic Tests Sales Value, by Type (2019-2030)
3.2.3 Global Cystic Fibrosis Diagnostic Tests Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospitals
4.1.2 Diagnostic Laboratories
4.1.3 Others
4.2 Global Cystic Fibrosis Diagnostic Tests Sales Value by Application
4.2.1 Global Cystic Fibrosis Diagnostic Tests Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Cystic Fibrosis Diagnostic Tests Sales Value, by Application (2019-2030)
4.2.3 Global Cystic Fibrosis Diagnostic Tests Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Cystic Fibrosis Diagnostic Tests Sales Value by Region
5.1.1 Global Cystic Fibrosis Diagnostic Tests Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Cystic Fibrosis Diagnostic Tests Sales Value by Region (2019-2024)
5.1.3 Global Cystic Fibrosis Diagnostic Tests Sales Value by Region (2025-2030)
5.1.4 Global Cystic Fibrosis Diagnostic Tests Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Cystic Fibrosis Diagnostic Tests Sales Value, 2019-2030
5.2.2 North America Cystic Fibrosis Diagnostic Tests Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Cystic Fibrosis Diagnostic Tests Sales Value, 2019-2030
5.3.2 Europe Cystic Fibrosis Diagnostic Tests Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Cystic Fibrosis Diagnostic Tests Sales Value, 2019-2030
5.4.2 Asia Pacific Cystic Fibrosis Diagnostic Tests Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Cystic Fibrosis Diagnostic Tests Sales Value, 2019-2030
5.5.2 South America Cystic Fibrosis Diagnostic Tests Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Cystic Fibrosis Diagnostic Tests Sales Value, 2019-2030
5.6.2 Middle East & Africa Cystic Fibrosis Diagnostic Tests Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Cystic Fibrosis Diagnostic Tests Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Cystic Fibrosis Diagnostic Tests Sales Value
6.3 United States
6.3.1 United States Cystic Fibrosis Diagnostic Tests Sales Value, 2019-2030
6.3.2 United States Cystic Fibrosis Diagnostic Tests Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Cystic Fibrosis Diagnostic Tests Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Cystic Fibrosis Diagnostic Tests Sales Value, 2019-2030
6.4.2 Europe Cystic Fibrosis Diagnostic Tests Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Cystic Fibrosis Diagnostic Tests Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Cystic Fibrosis Diagnostic Tests Sales Value, 2019-2030
6.5.2 China Cystic Fibrosis Diagnostic Tests Sales Value by Type (%), 2023 VS 2030
6.5.3 China Cystic Fibrosis Diagnostic Tests Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Cystic Fibrosis Diagnostic Tests Sales Value, 2019-2030
6.6.2 Japan Cystic Fibrosis Diagnostic Tests Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Cystic Fibrosis Diagnostic Tests Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Cystic Fibrosis Diagnostic Tests Sales Value, 2019-2030
6.7.2 South Korea Cystic Fibrosis Diagnostic Tests Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Cystic Fibrosis Diagnostic Tests Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Cystic Fibrosis Diagnostic Tests Sales Value, 2019-2030
6.8.2 Southeast Asia Cystic Fibrosis Diagnostic Tests Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Cystic Fibrosis Diagnostic Tests Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Cystic Fibrosis Diagnostic Tests Sales Value, 2019-2030
6.9.2 India Cystic Fibrosis Diagnostic Tests Sales Value by Type (%), 2023 VS 2030
6.9.3 India Cystic Fibrosis Diagnostic Tests Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Quidel Corporation
7.1.1 Quidel Corporation Profile
7.1.2 Quidel Corporation Main Business
7.1.3 Quidel Corporation Cystic Fibrosis Diagnostic Tests Products, Services and Solutions
7.1.4 Quidel Corporation Cystic Fibrosis Diagnostic Tests Revenue (US$ Million) & (2019-2024)
7.1.5 Quidel Corporation Recent Developments
7.2 Quest Diagnostics
7.2.1 Quest Diagnostics Profile
7.2.2 Quest Diagnostics Main Business
7.2.3 Quest Diagnostics Cystic Fibrosis Diagnostic Tests Products, Services and Solutions
7.2.4 Quest Diagnostics Cystic Fibrosis Diagnostic Tests Revenue (US$ Million) & (2019-2024)
7.2.5 Quest Diagnostics Recent Developments
7.3 Creative Diagnostics
7.3.1 Creative Diagnostics Profile
7.3.2 Creative Diagnostics Main Business
7.3.3 Creative Diagnostics Cystic Fibrosis Diagnostic Tests Products, Services and Solutions
7.3.4 Creative Diagnostics Cystic Fibrosis Diagnostic Tests Revenue (US$ Million) & (2019-2024)
7.3.5 Invitae Corporation Recent Developments
7.4 Invitae Corporation
7.4.1 Invitae Corporation Profile
7.4.2 Invitae Corporation Main Business
7.4.3 Invitae Corporation Cystic Fibrosis Diagnostic Tests Products, Services and Solutions
7.4.4 Invitae Corporation Cystic Fibrosis Diagnostic Tests Revenue (US$ Million) & (2019-2024)
7.4.5 Invitae Corporation Recent Developments
7.5 Asper Biogene
7.5.1 Asper Biogene Profile
7.5.2 Asper Biogene Main Business
7.5.3 Asper Biogene Cystic Fibrosis Diagnostic Tests Products, Services and Solutions
7.5.4 Asper Biogene Cystic Fibrosis Diagnostic Tests Revenue (US$ Million) & (2019-2024)
7.5.5 Asper Biogene Recent Developments
7.6 GeneDx
7.6.1 GeneDx Profile
7.6.2 GeneDx Main Business
7.6.3 GeneDx Cystic Fibrosis Diagnostic Tests Products, Services and Solutions
7.6.4 GeneDx Cystic Fibrosis Diagnostic Tests Revenue (US$ Million) & (2019-2024)
7.6.5 GeneDx Recent Developments
7.7 Illumina
7.7.1 Illumina Profile
7.7.2 Illumina Main Business
7.7.3 Illumina Cystic Fibrosis Diagnostic Tests Products, Services and Solutions
7.7.4 Illumina Cystic Fibrosis Diagnostic Tests Revenue (US$ Million) & (2019-2024)
7.7.5 Illumina Recent Developments
7.8 Elucigene Diagnostics
7.8.1 Elucigene Diagnostics Profile
7.8.2 Elucigene Diagnostics Main Business
7.8.3 Elucigene Diagnostics Cystic Fibrosis Diagnostic Tests Products, Services and Solutions
7.8.4 Elucigene Diagnostics Cystic Fibrosis Diagnostic Tests Revenue (US$ Million) & (2019-2024)
7.8.5 Elucigene Diagnostics Recent Developments
7.9 BillionToOne Inc.
7.9.1 BillionToOne Inc. Profile
7.9.2 BillionToOne Inc. Main Business
7.9.3 BillionToOne Inc. Cystic Fibrosis Diagnostic Tests Products, Services and Solutions
7.9.4 BillionToOne Inc. Cystic Fibrosis Diagnostic Tests Revenue (US$ Million) & (2019-2024)
7.9.5 BillionToOne Inc. Recent Developments
7.10 ELITechGroup
7.10.1 ELITechGroup Profile
7.10.2 ELITechGroup Main Business
7.10.3 ELITechGroup Cystic Fibrosis Diagnostic Tests Products, Services and Solutions
7.10.4 ELITechGroup Cystic Fibrosis Diagnostic Tests Revenue (US$ Million) & (2019-2024)
7.10.5 ELITechGroup Recent Developments
8 Industry Chain Analysis
8.1 Cystic Fibrosis Diagnostic Tests Industrial Chain
8.2 Cystic Fibrosis Diagnostic Tests Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Cystic Fibrosis Diagnostic Tests Sales Model
8.5.2 Sales Channel
8.5.3 Cystic Fibrosis Diagnostic Tests Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer